Foley Attorneys Submitted Two Amicus Briefs to the Federal Circuit Related to ACLU v. Myriad

10 November 2010 Media Contact: Jill Chanen News
Foley attorneys filed two amicus briefs with the Federal Circuit in the AMP et al. v. USPTO et al. (ACLU v. Myriad), a much discussed case relating to gene patents. Foley attorneys submitted one brief on behalf of Rosetta Genomics and George Mason University. Different Foley attorneys also filed a different brief on behalf of Alnylam Pharmaceuticals. Both briefs conclude that isolated DNA composition claims are patent eligible under current law, and should continue to meet the threshold of 35 U.S.C. § 101 when applying scientific facts to the law.

Related Services


Botnet Infecting Content Management Systems (CMSes) of 100,000’s Websites!
27 October 2020
Internet, IT & e-Discovery Blog
Charitable Planning in the Midst of Uncertainty
27 October 2020
2020 Election Resource Center
Managing Warranty Disputes in the Age of COVID-19
27 October 2020
Coronavirus Resource Center:Back to Business
Podcast Episode 19: Stephen Jones, Associate
27 October 2020
Foley Career Perspectives